CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Lipidomics in type 2 diabetic patients treated with an intestinal absorption inhibitor versus placebo: implications on metabolic learning and intestinal mucosa transdifferentiation
DOI 10.1055/s-2008-1076197
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Wycislo, G Liebisch, P Ugocsai, C Köhler, M Solleder, M Hanefeld, G Schmitz
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Electrospray ionization tandem mass spectrometry (ESI-MS/MS) allows the simultaneous analysis of a wide spectrum of lipid species (lipidomics) in plasma and other body fluids of patients to elucidate the metabolic pathophysiology of complex diseases like obesity, insulin resistance, type 2 Diabetes mellitus (T2D) or metabolic syndrome and to identify lipid biomarkers as surrogate biomarkers. Lipidomics also includes…
Zitieren
Zitierempfehlung
M Wycislo, G Liebisch, P Ugocsai, C Köhler, M Solleder, M Hanefeld, G Schmitz (2008) Lipidomics in type 2 diabetic patients treated with an intestinal absorption inhibitor versus placebo: implications on metabolic learning and intestinal mucosa transdifferentiation. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-2008-1076197
Mit CareLit weiterarbeiten